Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway

Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-l...

Full description

Saved in:
Bibliographic Details
Published inCancer nanotechnology Vol. 13; no. 1; pp. 1 - 21
Main Authors Liu, Fengjie, Lan, Meng, Ren, Baoqi, Li, Lihong, Zou, Tengteng, Kong, Zhaodi, Fan, Dongmei, Cai, Tiange, Cai, Yu
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.12.2022
Springer Nature B.V
BMC
Subjects
Online AccessGet full text
ISSN1868-6958
1868-6966
DOI10.1186/s12645-021-00110-x

Cover

Abstract Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression. Results Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers. Conclusions Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
AbstractList BackgroundBreast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression.ResultsCompared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers.ConclusionsEncapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression. Results Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers. Conclusions Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Abstract Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression. Results Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers. Conclusions Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
ArticleNumber 2
Author Zou, Tengteng
Kong, Zhaodi
Lan, Meng
Fan, Dongmei
Cai, Tiange
Cai, Yu
Liu, Fengjie
Ren, Baoqi
Li, Lihong
Author_xml – sequence: 1
  givenname: Fengjie
  surname: Liu
  fullname: Liu, Fengjie
  organization: College of Pharmacy, Jinan University
– sequence: 2
  givenname: Meng
  surname: Lan
  fullname: Lan, Meng
  organization: College of Pharmacy, Jinan University
– sequence: 3
  givenname: Baoqi
  surname: Ren
  fullname: Ren, Baoqi
  organization: Medical Department of Guangdong Hospital of Traditional Chinese Medicine
– sequence: 4
  givenname: Lihong
  surname: Li
  fullname: Li, Lihong
  organization: College of Pharmacy, Jinan University
– sequence: 5
  givenname: Tengteng
  surname: Zou
  fullname: Zou, Tengteng
  organization: College of Pharmacy, Jinan University
– sequence: 6
  givenname: Zhaodi
  surname: Kong
  fullname: Kong, Zhaodi
  organization: College of Pharmacy, Jinan University
– sequence: 7
  givenname: Dongmei
  surname: Fan
  fullname: Fan, Dongmei
  email: dongmeifan9@sina.com
  organization: Department of Gastroenterology, First Affiliated Hospital of Guangzhou University of Chinese Medicine
– sequence: 8
  givenname: Tiange
  surname: Cai
  fullname: Cai, Tiange
  email: caitiange@163.com
  organization: College of Life Sciences, Liaoning University
– sequence: 9
  givenname: Yu
  orcidid: 0000-0002-8532-7816
  surname: Cai
  fullname: Cai, Yu
  email: caiyu8@sohu.com
  organization: College of Pharmacy, Jinan University, Guangdong Key Lab of Traditional Chinese Medicine Information Technology, Jinan University
BookMark eNp9kc1u1DAUhSNUJErpC7CyxAYWZmwncZxlZtSBipap2tlbN_6ZekjsEGeg8yS8Lm6naqUu6o2t4_ude6_O--zIB2-y7CMlXykVfBYp40WJCaOYEEoJvnuTHacPgXnN-dHTuxTvstMYtySdvK5rUh9n_-bgFHTO4y6ANhrZ0DmFQDmN-6CddUmDrt31ziMPPgwwTk51JqLPywbPb5qfV3E2b74g5_VOGQS7KQy3sNknAV0ulrhCynRdRH8coOvVDe6NdjAl1yEX6LK5-oHAa9T8mmb9enWNBphu_8L-Q_bWQhfN6eN9kq2XZ-vFd3yx-na-aC6wKlg9YVpCbanKFbFc68LSsjIWqBaW5Zwxog0npK2qVqiqTGuD4oLbWrTcVDkT-Ul2frDVAbZyGF0P414GcPJBCONGPu4rQQmrmGqpoFDoVtetKC3lghWUlLW99_p08BrG8Htn4iS3YTf6NL1knFaUMlqxVMUOVWoMMY7GPnWlRN7HKQ9xyhSnfIhT3iVIvICUm2BywU8juO51ND-gMfXxGzM-T_UK9R99k7TZ
CitedBy_id crossref_primary_10_3390_cells12030458
crossref_primary_10_1016_j_ecoenv_2024_116973
crossref_primary_10_1002_smll_202310966
crossref_primary_10_1007_s12272_022_01397_z
crossref_primary_10_3390_cimb47030181
crossref_primary_10_1016_j_onano_2022_100081
crossref_primary_10_1016_j_ijbiomac_2025_140627
crossref_primary_10_1038_s41598_024_62409_0
crossref_primary_10_1186_s12645_023_00181_y
crossref_primary_10_3390_pharmaceutics15041186
crossref_primary_10_1080_17425247_2022_2139370
crossref_primary_10_1016_j_cbi_2024_111356
crossref_primary_10_1007_s11033_024_09325_8
crossref_primary_10_1016_j_jddst_2023_104161
crossref_primary_10_1088_1361_6528_adad7a
crossref_primary_10_1016_j_ccr_2024_215754
crossref_primary_10_1002_cbdv_202301122
crossref_primary_10_1016_j_ijpharm_2024_124919
crossref_primary_10_1080_09205063_2024_2429325
crossref_primary_10_1016_j_biopha_2024_117327
crossref_primary_10_1186_s12645_023_00237_z
crossref_primary_10_1016_j_sbsr_2023_100571
crossref_primary_10_1007_s00210_023_02907_6
crossref_primary_10_1016_j_mtcomm_2022_104561
crossref_primary_10_1016_j_ijbiomac_2025_140038
crossref_primary_10_1515_biol_2022_1000
crossref_primary_10_3390_ph16010092
crossref_primary_10_1016_j_apsb_2024_03_019
crossref_primary_10_1002_cbdv_202301767
crossref_primary_10_1002_cbin_12081
Cites_doi 10.1007/s11010-019-03667-9
10.1016/j.ctrv.2008.09.005
10.2147/OTT.S217101
10.3892/mmr.2017.7757
10.1038/nrd2803
10.1038/aps.2009.166
10.2147/DDDT.S176403
10.1016/j.jddst.2021.102603
10.1016/S0378-5173(03)00134-0
10.1016/j.phrs.2010.10.012
10.1007/s12272-010-0809-x
10.1016/j.semcdb.2017.05.023
10.1146/annurev-immunol-042617-053010
10.3322/caac.21590
10.1038/s41419-019-1492-6
10.1016/j.biopha.2019.109139
10.3390/nu11071514
10.1186/s12943-020-1138-4
10.18632/oncotarget.27677
10.3892/or.2011.1599
10.1186/s11671-016-1586-3
10.1007/s10495-017-1424-9
10.1001/jama.2018.19323
10.1089/ars.2013.5746
10.1016/j.cmet.2017.04.004
10.1016/j.jmb.2016.02.027
10.1016/j.canlet.2013.11.019
10.1016/j.ijpharm.2004.08.015
10.1080/21691401.2018.1548468
10.1038/s41571-020-0341-y
10.1155/2016/5293284
10.1016/j.canlet.2016.03.042
10.1016/j.cis.2017.06.012
10.3390/ijms18051088
10.1016/j.phrs.2020.105387
10.3390/pharmaceutics12020107
10.1039/C8TB02477D
ContentType Journal Article
Copyright The Author(s) 2022
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
8AO
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
L6V
M0S
M7S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
DOA
DOI 10.1186/s12645-021-00110-x
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
Technology Collection
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
Health & Medical Collection (Alumni)
Engineering Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
Publicly Available Content Database
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
Engineering Collection
Engineering Database
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1868-6966
EndPage 21
ExternalDocumentID oai_doaj_org_article_ac8fc2cb181a4dbd9b85f168241059f8
10_1186_s12645_021_00110_x
GrantInformation_xml – fundername: projects of international cooperation and exchanges of national natural science foundation of china
  grantid: 82020108033
– fundername: natural science foundation of guangdong
  grantid: 2019A1515011286
GroupedDBID ---
-58
-5G
-A0
-BR
0R~
0VY
1N0
2JY
2VQ
30V
3V.
4.4
408
409
40D
7X7
875
8AO
8FE
8FG
8FI
8FJ
8TC
AAFWJ
AAJSJ
AAKKN
AAYZH
ABEEZ
ABJCF
ABUWG
ACACY
ACGFS
ACIWK
ACULB
ADBBV
ADINQ
ADUKV
AFGXO
AFKRA
AFWTZ
AGJBK
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
BAPOH
BCNDV
BENPR
BFQNJ
BGLVJ
BGNMA
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
EBLON
EBS
EJD
F5P
FYUFA
GQ6
GQ8
GROUPED_DOAJ
HCIFZ
HF~
HMCUK
HMJXF
HZ~
IZIGR
KOV
L6V
M4Y
M7S
M~E
NU0
O9-
O93
OK1
P9N
PIMPY
PQQKQ
PROAC
PTHSS
QOS
R9I
RSV
S1Z
S27
S3B
SCM
SOJ
T13
TSV
TUS
U2A
UKHRP
WK8
Z45
Z85
~A9
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
PUEGO
ID FETCH-LOGICAL-c429t-15a9f1c3c0f6dd4f157efa1d8f236220de600b77b8c75000ac686f98b6e73283
IEDL.DBID 7X7
ISSN 1868-6958
IngestDate Wed Aug 27 01:27:46 EDT 2025
Fri Jul 25 11:04:51 EDT 2025
Tue Jul 01 02:42:20 EDT 2025
Thu Apr 24 23:13:56 EDT 2025
Fri Feb 21 02:46:32 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Albumin nanoparticles
Signal pathway
Breast cancer
Autophagy
Baicalin
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c429t-15a9f1c3c0f6dd4f157efa1d8f236220de600b77b8c75000ac686f98b6e73283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-8532-7816
OpenAccessLink https://www.proquest.com/docview/2617112172?pq-origsite=%requestingapplication%
PQID 2617112172
PQPubID 2034790
PageCount 21
ParticipantIDs doaj_primary_oai_doaj_org_article_ac8fc2cb181a4dbd9b85f168241059f8
proquest_journals_2617112172
crossref_primary_10_1186_s12645_021_00110_x
crossref_citationtrail_10_1186_s12645_021_00110_x
springer_journals_10_1186_s12645_021_00110_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-12-01
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Vienna
PublicationPlace_xml – name: Vienna
– name: Heidelberg
PublicationSubtitle Basic,Translational and Clinical Research
PublicationTitle Cancer nanotechnology
PublicationTitleAbbrev Cancer Nano
PublicationYear 2022
Publisher Springer Vienna
Springer Nature B.V
BMC
Publisher_xml – name: Springer Vienna
– name: Springer Nature B.V
– name: BMC
References Waks, Winer (CR30) 2019; 321
Wei, Xiaojun, Peilong (CR31) 2020; 121
Langer, Balthasar, Vogel, Dinauer, von Briesen, Schubert (CR12) 2003; 257
Ahmed, Rashed, Fayez, Farouk, Shamma (CR1) 2020
De Cicco, Catani, Gasperi, Sibilano, Quaglietta, Savini (CR4) 2019
Siegel, Miller, Jemal (CR25) 2020; 70
Duan, Guo, Pei, Wang, Li, Xiong (CR5) 2019; 12
Li-Weber (CR17) 2009; 35
Kimmelman, White (CR11) 2017; 25
Zhang, Hou, Zhang, Hu, Wang (CR35) 2010; 33
Sui, Kong, Ye, Han, Zhou, Zhang (CR27) 2014; 344
Li, He, Ma (CR14) 2020; 19
Mancias, Kimmelman (CR18) 2016; 428
Shen, Li, Kohama, Oneill, Bi (CR24) 2011; 63
Tao, Chuah, Xu, Wang (CR28) 2019; 7
Zhu, Fang, Wang, Fei, Tang, Liu (CR41) 2018; 12
Yang, Lian (CR33) 2020; 467
Gao, Zhou, Li, Cong, Jiang, Wang (CR6) 2017; 16
Gao, Liu, Wang, Hu, He, Gu (CR7) 2018; 53
Kim, Park, Kim, Yu, Park, Kim (CR10) 2017
Moloney, Cotter (CR20) 2018; 80
Singh, Meena, Luqman (CR26) 2021; 164
Zou, Chang, Li, Wang (CR42) 2017; 22
Lee, Ko, Hwang, Heo, Lee, Heo (CR13) 2016; 11
Zhou, Zhang, Kuang, Gong, Jiang, Lin (CR40) 2017; 38
Meng, Liu, Lan, Zou, Li, Cai (CR19) 2021; 65
Trachootham, Alexandre, Huang (CR29) 2009; 8
Kaminskyy, Zhivotovsky (CR9) 2014; 21
Xiang, Zhang, Jin, Tian, Cheng, Wang (CR32) 2020; 45
Nagata (CR21) 2018; 36
Zhang, He, Ye, Zhu, Hu, Shen (CR37) 2019; 10
Peng, Fu, Guo, Zhang, Di, Jiang (CR22) 2015; 14
Zhang, Hou, Mao, Wei, Song, Lu (CR34) 2004; 287
Hung, Pan, Hu (CR8) 2016; 2016
Zhang, Tang, Liu, Li, Hou, Gao (CR36) 2012; 27
Liu, Dong, Liu, Xiao (CR16) 2020; 11
Zhao, Zhao, Zu, Li, Zhang, Jiang (CR38) 2010; 5
Bhushan, Khanadeev, Khlebtsov, Khlebtsov, Gopinath (CR2) 2017; 246
Zhou, Wang, Zhang, Lu, Wang, Motoo (CR39) 2009; 30
Lian, Wu, Feng, Deng, Zhong, Zhao (CR15) 2019; 47
Carneiro, El-Deiry (CR3) 2020; 17
Prasad, Gupta, Tyagi (CR23) 2017; 387
X Duan (110_CR5) 2019; 12
S Yang (110_CR33) 2020; 467
G Zhang (110_CR37) 2019; 10
D Zhao (110_CR38) 2010; 5
F Meng (110_CR19) 2021; 65
S Nagata (110_CR21) 2018; 36
X Sui (110_CR27) 2014; 344
JN Moloney (110_CR20) 2018; 80
P De Cicco (110_CR4) 2019
C Gao (110_CR6) 2017; 16
S Prasad (110_CR23) 2017; 387
L Zhang (110_CR34) 2004; 287
RL Siegel (110_CR25) 2020; 70
Z Shen (110_CR24) 2011; 63
B Lian (110_CR15) 2019; 47
D Trachootham (110_CR29) 2009; 8
T Zhou (110_CR40) 2017; 38
D-K Liu (110_CR16) 2020; 11
Y Zhu (110_CR41) 2018; 12
B Bhushan (110_CR2) 2017; 246
Y-C Hung (110_CR8) 2016; 2016
AC Kimmelman (110_CR11) 2017; 25
K Langer (110_CR12) 2003; 257
Y Gao (110_CR7) 2018; 53
VO Kaminskyy (110_CR9) 2014; 21
JD Mancias (110_CR18) 2016; 428
C Tao (110_CR28) 2019; 7
Q Zhou (110_CR39) 2009; 30
IS Ahmed (110_CR1) 2020
BA Carneiro (110_CR3) 2020; 17
Y Peng (110_CR22) 2015; 14
D Lee (110_CR13) 2016; 11
L Zhang (110_CR35) 2010; 33
W Xiang (110_CR32) 2020; 45
X Li (110_CR14) 2020; 19
M Li-Weber (110_CR17) 2009; 35
Z Zou (110_CR42) 2017; 22
T Wei (110_CR31) 2020; 121
X Zhang (110_CR36) 2012; 27
S Singh (110_CR26) 2021; 164
K-Y Kim (110_CR10) 2017
AG Waks (110_CR30) 2019; 321
References_xml – volume: 467
  start-page: 1
  issue: 1–2
  year: 2020
  end-page: 12
  ident: CR33
  article-title: ROS and diseases: role in metabolism and energy supply
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-019-03667-9
– volume: 35
  start-page: 57
  issue: 1
  year: 2009
  end-page: 68
  ident: CR17
  article-title: New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2008.09.005
– volume: 12
  start-page: 11183
  year: 2019
  end-page: 11193
  ident: CR5
  article-title: Baicalin inhibits cell viability, migration and invasion in breast cancer by regulating miR-338-3p and MORC4
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S217101
– volume: 16
  start-page: 8729
  issue: 6
  year: 2017
  end-page: 8734
  ident: CR6
  article-title: Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.7757
– volume: 45
  start-page: 245
  issue: 1
  year: 2020
  end-page: 254
  ident: CR32
  article-title: RCE-4, a potential anti-cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells
  publication-title: Int J Mol Med
– volume: 8
  start-page: 579
  issue: 7
  year: 2009
  end-page: 591
  ident: CR29
  article-title: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2803
– volume: 30
  start-page: 1648
  issue: 12
  year: 2009
  end-page: 1658
  ident: CR39
  article-title: The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2009.166
– volume: 12
  start-page: 3247
  year: 2018
  end-page: 3261
  ident: CR41
  article-title: Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca(2+)-dependent pathway
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S176403
– volume: 65
  start-page: 102603
  year: 2021
  ident: CR19
  article-title: Preparation and evaluation of folate-modified albumin baicalin-loaded nanoparticles for the targeted treatment of breast cancer
  publication-title: J Drug Deliv Sci Technol.
  doi: 10.1016/j.jddst.2021.102603
– volume: 257
  start-page: 169
  issue: 1–2
  year: 2003
  end-page: 180
  ident: CR12
  article-title: Optimization of the preparation process for human serum albumin (HSA) nanoparticles
  publication-title: Int J Pharm
  doi: 10.1016/S0378-5173(03)00134-0
– volume: 5
  start-page: 669
  year: 2010
  end-page: 677
  ident: CR38
  article-title: Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles
  publication-title: Int J Nanomedicine
– volume: 63
  start-page: 51
  issue: 1
  year: 2011
  end-page: 58
  ident: CR24
  article-title: Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2010.10.012
– volume: 33
  start-page: 1193
  issue: 8
  year: 2010
  end-page: 1198
  ident: CR35
  article-title: Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles
  publication-title: Arch Pharm Res
  doi: 10.1007/s12272-010-0809-x
– volume: 80
  start-page: 50
  year: 2018
  end-page: 64
  ident: CR20
  article-title: ROS signalling in the biology of cancer
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2017.05.023
– volume: 36
  start-page: 489
  year: 2018
  end-page: 517
  ident: CR21
  article-title: Apoptosis and clearance of apoptotic cells
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-042617-053010
– volume: 14
  start-page: 251
  issue: 1
  year: 2015
  end-page: 261
  ident: CR22
  article-title: Effects and mechanism of baicalin on apoptosis of cervical cancer hela cells in-vitro
  publication-title: Iran J Pharm Res
– volume: 70
  start-page: 7
  issue: 1
  year: 2020
  end-page: 30
  ident: CR25
  article-title: Cancer statistics, 2020
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21590
– volume: 10
  start-page: 255
  issue: 4
  year: 2019
  ident: CR37
  article-title: β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1492-6
– volume: 121
  start-page: 109139
  year: 2020
  ident: CR31
  article-title: Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109139
– year: 2019
  ident: CR4
  article-title: Nutrition and breast cancer: a literature review on prevention, treatment and recurrence
  publication-title: Nutrients
  doi: 10.3390/nu11071514
– volume: 19
  start-page: 12
  issue: 1
  year: 2020
  ident: CR14
  article-title: Autophagy and autophagy-related proteins in cancer
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-1138-4
– volume: 11
  start-page: 2863
  issue: 29
  year: 2020
  end-page: 2872
  ident: CR16
  article-title: Baicalin inhibits the TGF-β1/p-Smad3 pathway to suppress epithelial-mesenchymal transition-induced metastasis in breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27677
– volume: 27
  start-page: 1128
  issue: 4
  year: 2012
  end-page: 1134
  ident: CR36
  article-title: Autophagy induced by baicalin involves downregulation of CD147 in SMMC-7721 cells in vitro
  publication-title: Oncol Rep
  doi: 10.3892/or.2011.1599
– volume: 11
  start-page: 381
  issue: 1
  year: 2016
  ident: CR13
  article-title: Use of baicalin-conjugated gold nanoparticles for apoptotic induction of breast cancer cells
  publication-title: Nanoscale Res Lett
  doi: 10.1186/s11671-016-1586-3
– volume: 22
  start-page: 1321
  issue: 11
  year: 2017
  end-page: 1335
  ident: CR42
  article-title: Induction of reactive oxygen species: an emerging approach for cancer therapy
  publication-title: Apoptosis
  doi: 10.1007/s10495-017-1424-9
– volume: 53
  start-page: 2727
  issue: 6
  year: 2018
  end-page: 2736
  ident: CR7
  article-title: Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo
  publication-title: Int J Oncol
– volume: 321
  start-page: 288
  issue: 3
  year: 2019
  end-page: 300
  ident: CR30
  article-title: Breast cancer treatment: a review
  publication-title: JAMA
  doi: 10.1001/jama.2018.19323
– volume: 21
  start-page: 86
  issue: 1
  year: 2014
  end-page: 102
  ident: CR9
  article-title: Free radicals in cross talk between autophagy and apoptosis
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2013.5746
– volume: 25
  start-page: 1037
  issue: 5
  year: 2017
  end-page: 1043
  ident: CR11
  article-title: Autophagy and tumor metabolism
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.04.004
– volume: 428
  start-page: 1659
  year: 2016
  end-page: 1680
  ident: CR18
  article-title: Mechanisms of selective autophagy in normal physiology and cancer
  publication-title: J Mol Biol
  doi: 10.1016/j.jmb.2016.02.027
– volume: 344
  start-page: 174
  issue: 2
  year: 2014
  end-page: 179
  ident: CR27
  article-title: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.11.019
– volume: 287
  start-page: 155
  issue: 1–2
  year: 2004
  end-page: 162
  ident: CR34
  article-title: Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2004.08.015
– volume: 47
  start-page: 154
  issue: 1
  year: 2019
  end-page: 165
  ident: CR15
  article-title: Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors
  publication-title: Artif Cells Nanomed Biotechnol.
  doi: 10.1080/21691401.2018.1548468
– volume: 17
  start-page: 395
  issue: 7
  year: 2020
  end-page: 417
  ident: CR3
  article-title: Targeting apoptosis in cancer therapy
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-0341-y
– volume: 2016
  start-page: 5293284
  year: 2016
  ident: CR8
  article-title: Roles of reactive oxygen species in anticancer therapy with bunge
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2016/5293284
– volume: 387
  start-page: 95
  year: 2017
  end-page: 105
  ident: CR23
  article-title: Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
  publication-title: Cancer Lett Ireland
  doi: 10.1016/j.canlet.2016.03.042
– volume: 38
  start-page: 3599
  issue: 6
  year: 2017
  end-page: 3607
  ident: CR40
  article-title: Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling
  publication-title: Oncol Rep
– volume: 246
  start-page: 13
  year: 2017
  end-page: 39
  ident: CR2
  article-title: Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery
  publication-title: Adv Colloid Interface Sci
  doi: 10.1016/j.cis.2017.06.012
– year: 2017
  ident: CR10
  article-title: Inhibition of Autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18051088
– volume: 164
  start-page: 105387
  year: 2021
  ident: CR26
  article-title: Baicalin mediated regulation of key signaling pathways in cancer
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2020.105387
– year: 2020
  ident: CR1
  article-title: Nanoparticle-mediated dual targeting: an approach for enhanced baicalin delivery to the liver
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics12020107
– volume: 7
  start-page: 357
  issue: 3
  year: 2019
  end-page: 367
  ident: CR28
  article-title: Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications
  publication-title: J Mater Chem B
  doi: 10.1039/C8TB02477D
– volume: 246
  start-page: 13
  year: 2017
  ident: 110_CR2
  publication-title: Adv Colloid Interface Sci
  doi: 10.1016/j.cis.2017.06.012
– volume: 53
  start-page: 2727
  issue: 6
  year: 2018
  ident: 110_CR7
  publication-title: Int J Oncol
– volume: 387
  start-page: 95
  year: 2017
  ident: 110_CR23
  publication-title: Cancer Lett Ireland
  doi: 10.1016/j.canlet.2016.03.042
– volume: 27
  start-page: 1128
  issue: 4
  year: 2012
  ident: 110_CR36
  publication-title: Oncol Rep
  doi: 10.3892/or.2011.1599
– volume: 19
  start-page: 12
  issue: 1
  year: 2020
  ident: 110_CR14
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-1138-4
– volume: 45
  start-page: 245
  issue: 1
  year: 2020
  ident: 110_CR32
  publication-title: Int J Mol Med
– volume: 17
  start-page: 395
  issue: 7
  year: 2020
  ident: 110_CR3
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-0341-y
– volume: 287
  start-page: 155
  issue: 1–2
  year: 2004
  ident: 110_CR34
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2004.08.015
– volume: 344
  start-page: 174
  issue: 2
  year: 2014
  ident: 110_CR27
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.11.019
– volume: 8
  start-page: 579
  issue: 7
  year: 2009
  ident: 110_CR29
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2803
– volume: 12
  start-page: 3247
  year: 2018
  ident: 110_CR41
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S176403
– volume: 428
  start-page: 1659
  year: 2016
  ident: 110_CR18
  publication-title: J Mol Biol
  doi: 10.1016/j.jmb.2016.02.027
– volume: 10
  start-page: 255
  issue: 4
  year: 2019
  ident: 110_CR37
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1492-6
– volume: 47
  start-page: 154
  issue: 1
  year: 2019
  ident: 110_CR15
  publication-title: Artif Cells Nanomed Biotechnol.
  doi: 10.1080/21691401.2018.1548468
– volume: 16
  start-page: 8729
  issue: 6
  year: 2017
  ident: 110_CR6
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.7757
– volume: 12
  start-page: 11183
  year: 2019
  ident: 110_CR5
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S217101
– volume: 164
  start-page: 105387
  year: 2021
  ident: 110_CR26
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2020.105387
– volume: 5
  start-page: 669
  year: 2010
  ident: 110_CR38
  publication-title: Int J Nanomedicine
– volume: 63
  start-page: 51
  issue: 1
  year: 2011
  ident: 110_CR24
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2010.10.012
– volume: 7
  start-page: 357
  issue: 3
  year: 2019
  ident: 110_CR28
  publication-title: J Mater Chem B
  doi: 10.1039/C8TB02477D
– volume: 30
  start-page: 1648
  issue: 12
  year: 2009
  ident: 110_CR39
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2009.166
– volume: 22
  start-page: 1321
  issue: 11
  year: 2017
  ident: 110_CR42
  publication-title: Apoptosis
  doi: 10.1007/s10495-017-1424-9
– volume: 70
  start-page: 7
  issue: 1
  year: 2020
  ident: 110_CR25
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21590
– volume: 257
  start-page: 169
  issue: 1–2
  year: 2003
  ident: 110_CR12
  publication-title: Int J Pharm
  doi: 10.1016/S0378-5173(03)00134-0
– volume: 65
  start-page: 102603
  year: 2021
  ident: 110_CR19
  publication-title: J Drug Deliv Sci Technol.
  doi: 10.1016/j.jddst.2021.102603
– volume: 321
  start-page: 288
  issue: 3
  year: 2019
  ident: 110_CR30
  publication-title: JAMA
  doi: 10.1001/jama.2018.19323
– volume: 467
  start-page: 1
  issue: 1–2
  year: 2020
  ident: 110_CR33
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-019-03667-9
– volume: 36
  start-page: 489
  year: 2018
  ident: 110_CR21
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-042617-053010
– volume: 25
  start-page: 1037
  issue: 5
  year: 2017
  ident: 110_CR11
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.04.004
– volume: 38
  start-page: 3599
  issue: 6
  year: 2017
  ident: 110_CR40
  publication-title: Oncol Rep
– volume: 11
  start-page: 381
  issue: 1
  year: 2016
  ident: 110_CR13
  publication-title: Nanoscale Res Lett
  doi: 10.1186/s11671-016-1586-3
– volume: 33
  start-page: 1193
  issue: 8
  year: 2010
  ident: 110_CR35
  publication-title: Arch Pharm Res
  doi: 10.1007/s12272-010-0809-x
– year: 2019
  ident: 110_CR4
  publication-title: Nutrients
  doi: 10.3390/nu11071514
– volume: 14
  start-page: 251
  issue: 1
  year: 2015
  ident: 110_CR22
  publication-title: Iran J Pharm Res
– year: 2020
  ident: 110_CR1
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics12020107
– volume: 80
  start-page: 50
  year: 2018
  ident: 110_CR20
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2017.05.023
– volume: 21
  start-page: 86
  issue: 1
  year: 2014
  ident: 110_CR9
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2013.5746
– volume: 35
  start-page: 57
  issue: 1
  year: 2009
  ident: 110_CR17
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2008.09.005
– volume: 121
  start-page: 109139
  year: 2020
  ident: 110_CR31
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109139
– volume: 11
  start-page: 2863
  issue: 29
  year: 2020
  ident: 110_CR16
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27677
– year: 2017
  ident: 110_CR10
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18051088
– volume: 2016
  start-page: 5293284
  year: 2016
  ident: 110_CR8
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2016/5293284
SSID ssj0000399909
Score 2.4166584
Snippet Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous...
BackgroundBreast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous...
Abstract Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor...
SourceID doaj
proquest
crossref
springer
SourceType Open Website
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Albumin nanoparticles
Albumins
Antiproliferatives
Apoptosis
Autophagy
Baicalin
Biochemistry
Biomedical Engineering and Bioengineering
Breast cancer
Cancer Research
Cell cycle
Chemistry and Materials Science
Flow cytometry
Fluorescence
Folic acid
Materials Science
Nanoparticles
Nanotechnology
Proteins
Signal pathway
Signaling
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLAgpioSAfegCBtYmT-HHMVqyqom2rdpF6i_xEUdtsxW6h_SX8XWacbB9IwIWr40jWeJz5Jv7mG0K2veM6D0YzFW3FsBQSzpwOzFkXdFFKV_rEttgXu1_KvZPq5E6rL-SE9fLAveHGxqnouLMQiUzprddWVTEXiiM_UcdU5pvp7E4ylb7BEHd14negHDwTulLrihklxsscYAAWJkMmjfGPXd2LSkm8_x7i_O2SNMWe6RPyeACNtO4X-5Q8CN0z8nA2XItvkp8Tg7ZuO3a2MD54GlHtlxrXena-8G0EnEkTEbntaGc6SJQHPhx9N63Z5LjeP1yOJ_V7Chk67DU1l6g3YL5ewwCd7UyZpPiHf0m_t4YeHRyzVHACYJVeFIrO6sPP1HSe1qer8fn84Ihin-Mf5vo5mU8_zXd22dBxgTmISyuWV0bH3BUui8L7MuaVDNHkXkUOgY5nPgA-slJa5SR2UjBOKBG1siKg6E_xgmx0iy68JLTgUkcuVfDclDZKa3n0wRRRRlsarUYkXxu8cYMaOTbFOGtSVqJE029SA5uUeHdZczUiH27euei1OP46e4L7eDMTdbTTAHhXM1i5-Zd3jcjW2gua4XAvGxSxB5gK0G9EPq494_bxn5f06n8s6TV5xLEEI1FqtsjG6ttleAPAaGXfpjPwC50QBSg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELZQkRAXVF4iUJAPHEBgJevd9eO4iYgqUNqqDVJvlp9oRbupSFroL-HvMuNsAkWAxNXrXVme8c43nplvCHkZPNdFtJqp5GqGpZBw5nRk3vmoy0r6KuRsiwOx_7F6f1qf9jQ5WAvza_y-UGK4LMBiYw0xOL1oqhjgxds1_HhRmydisr1PGYGl1TmjAwngmdC12tTI_PEzN-xQpuu_gTF_C4tmazPdJfd6mEibtVzvk1uxe0DuzPpA-EPyfWxxd9uOnS1siIEm5Pel1reBnS9CmwBZ0px63Ha0sx24xn0GHH01bdj4pDk4Wg7HzWsKPjlIl9pLZBiwn65hgM4mUyYp3ukv6VVr6fHhCcslJgBP6UWp6Kw5-kBtF2jzeTU8nx8eU-xs_NVePyLz6bv5ZJ_1PRaYB0u0YkVtdSp86UdJhFClopYx2SKoxMG08VGIgIiclE55ib0TrBdKJK2ciEjzUz4mO92ii08ILbnUiUsVA7eVS9I5nkK0ZZLJVVarASk2G258zz-ObTDOTPZDlDBrIRkQUs60G5lvA_Jm-87Fmn3jn7PHKMftTGTOzgOgUKbfZWO9Sp57B8jGVsEF7VSdCqE45rvqBMvc22iB6Y_z0iBtPQBTAHsD8najGT8f_31JT_9v-jNyl2N5RU6X2SM7qy-X8TmAnpV7kbX9B2xZ9VY
  priority: 102
  providerName: Springer Nature
Title Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway
URI https://link.springer.com/article/10.1186/s12645-021-00110-x
https://www.proquest.com/docview/2617112172
https://doaj.org/article/ac8fc2cb181a4dbd9b85f168241059f8
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxsxEBZtAqWX0id1mxodemhphb3y7ko6lbWJG1zsGNuB3BY9g0mydmOnTX5J_25n5LVDCs1FC1rtIjSS5tNo5htCPjrLVeK1YjKYjGEoJKw55Zk11qtOKmzqorfFKD86SQen2WltcFvVbpXbPTFu1G5h0UbeQuZwwAagb78tfzLMGoW3q3UKjcdkPwEkgqkbxKnY2VjaoH1V9PJAUniWq0xu42Zk3lolAAYwPBnO06gF2c093RQp_O_hzn-uSqMG6j8nz2roSIuNrF-QR756SZ4M68vxV-RPV-OIzyt2sdDOOxqQ85dqO3fscuHmAdAmje7I84pWuoLjcu0VRz_1C9adFqPxqtUtPlM4p4PEqb5G1gF9dgsVdNjrM0HRzr-iv-aaTo6nLIadAGSly46kw2L8g-rK0eJ83bqcHU8oZjv-rW9fk1n_cNY7YnXeBWZBO61ZkmkVEtux7ZA7l4YkEz7oxMnAQd3xtvOAkowQRlqB-RS0zWUelDS5R-qfzhuyVy0q_5bQDhcqcCG94zo1QRjDg_O6E0QwqVayQZLtgJe25iTH1BgXZTybyLzcCKkEIUXvu3Z50yBfdt8sN4wcD7buohx3LZFNO1Ysrs7KepRLbWWw3BpAOzp1xikjs5DkkqMPrArQzYPtLCjrJb4q7yZkg3zdzoy71__v0ruH__aePOUYYhFdZg7I3vrq2n8A4LM2zTi7oZT9702yXxSD6QCe3cPReAK1PZ5imfea0bAA5Qkv_gIaUwOd
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKgEXxFMNFPABJBBYyXpf9qFCm9IoJU0apUHqbeVntaLdhCalzS_h1_Df8Di7qYpEb716vZblGc98tme-QeidVpQHRnDCrIwJpEK6PccNUVIZHkapirSPthgmve_Rt-P4eAP9qXNhIKyytoneUOupgjvyFjCHO2zg_O2X2U8CVaPgdbUuoSGq0gp6x1OMVYkdfbO8dEe4-c7-Vyfv95R29ya7PVJVGSDK2eIFCWLBbaBC1baJ1pEN4tRYEWhmqTPutK2NwwQyTSVTKVQPECphieVMJgaIbkI37D20GcH9SQNtdvaGo_H6kqft3D_3YSbASk8SHrM6cYclrXng0AjkR7sDPbhhcnXDOfoaAjeA7z9vtd4Fdh-jRxV2xdlK2Z6gDVM-RfcH1ev8M_S7I0DkRUlOp0IbjS2QDmOhCk3OprqwDu5iHw9dlLgUpTuvV2F5-EM3I52jbDiatzrZR1yU2qkcFhdAeyBOlq4BD3a7JMXw0DDHvwqBx4dHxOe9OMyMZyHDg2zUx6LUOPuxaJ1NDscYyi1fiuVzNLkLkbxAjXJami2EQ5pyS1NmNBWRtKmU1GojQptaGQnOmiioFzxXFSk61OY4zf3hiCX5Ski5E5IP_2vnV030af3PbEUJcmvvDshx3RPovH3D9Pwkr1Y5F4pZRZV0cEtEWmouWWyDhFEIwuXWTXO71oK8sjHz_HpHNNHnWjOuP_9_Si9vH-0tetCbDA7yg_1h_xV6SCHfw8fvbKPG4vzCvHYobCHfVLqOUX7Hu-svqek-ig
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEE-RUmAPIIFglXj92j0g5LSYlpA0aoPUm7XPyqK1Q5PS5pfwW_h3zG7sVEWit17X9sryvL71fDOD0GutKA-M4IRZGRNXCgk2xw1RUhkeRqmKtGdbjJLd79HXo_hoDf1pa2EcrbL1id5R61q5f-Rd1zkcsAHE265taBHjnfzT9CdxE6RcprUdp7FUkYFZXMDxbfZxbwdk_YbS_PNke5c0EwaIAj88J0EsuA1UqHo20TqyQZwaKwLNLAXHTnvaAB6QaSqZSt3kAKESlljOZGJck5sQtr2D7qYhmIkrUs-_rH7v9CDwc08wcf3oScJj1pbssKQ7CwCHuMpoOMq7AEwur4VFPz3gGuT9J0vrg1_-AN1vUCvOlmr2EK2Z6hHaGDZ5-cfod184YZcVOamFNhpb124YC1Vqclrr0gLQxZ4JXVa4EhWc1BtCHn6bZ6R_mI3Gs24_e4fLSoOyYXHuGh6I4wUs4OF2TlLsUgwz_KsU-GD_kPiKF0DLeBoyPMzGAywqjbMf8-7pZP8Au0HLF2LxBE1uQyBP0XpVV-YZwiFNuaUpM5qKSNpUSmq1EaFNrYwEZx0UtB-8UE07dDeV46TwxyKWFEshFSAkT_zrFZcd9H71zHTZDOTGu_tOjqs7XSNvv1CfHRfNVy6EYlZRJQFoiUhLzSWLbZAw6ui33MJrbrVaUDTeZVZc2UIHfWg14-ry_19p8-bdXqENsKni295o8Bzdo67QwxN3ttD6_OzcvAD4NZcvvaJjVNyyYf0F4ko8Jg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baicalin-loaded+folic+acid-modified+albumin+nanoparticles+%28FA-BSANPs%2FBA%29+induce+autophagy+in+MCF-7+cells+via+ROS-mediated+p38+MAPK+and+Akt%2FmTOR+pathway&rft.jtitle=Cancer+nanotechnology&rft.au=Liu+Fengjie&rft.au=Meng%2C+Lan&rft.au=Ren+Baoqi&rft.au=Li%2C+Lihong&rft.date=2022-12-01&rft.pub=Springer+Nature+B.V&rft.issn=1868-6958&rft.eissn=1868-6966&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1186%2Fs12645-021-00110-x&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-6958&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-6958&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-6958&client=summon